Updates are available Correction dated 2025-05-24
Click to view Correction: https://doi.org/10.1007/s40121-025-01163-w
-
Authors
Katzenellenbogen, Guy
Canetti, Michal https://orcid.org/0000-0001-5235-3447
Margalit, Ili
Shusterman, Yonatan
Simchovitz-Gesher, Alon
Naveh, Lior
Baharav, Nadav
Goldenfeld, Miki
Belkin, Ana
Brod, Marina
Wieder-Finesod, Anat
Leshem, Eyal
Magiel, Erez
Levy, Itzchak
Lustig, Yaniv
Indenbaum, Victoria
Maggio, Nicola
Dekel, Shahar
Mechnik, Bella
Peretz, Yovel
Barda, Noam
Tafesh, Amir
Yahav, Dafna
Regev-Yochay, Gili
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 18 March 2025
First Online: 3 April 2025
Change Date: 8 May 2025
Change Type: Update
Change Details: The author’s name 'Alon Simchovitz-Gesher' was incorrectly written as 'Simchovitz-Gesher'.
Change Date: 24 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-025-01163-w
Declarations
:
: Dafna Yahav has collaborative research with Pfizer and an investigator-initiated study supported by Shionogi. Gili Regev-Yoachay reports institutional grant funding of studies unrelated to the current study from Pfizer, Moderna, and Astrazeneca, consulting/honoraria from MSD, GSK, Astrazeneca, Pfizer, and Moderna. Yaniv Lustig reports an institutional grant from Pfizer. Itzchak Levy reports consulting/honoraria from ViiV, GSK, and Gilaed. Eyal Leshem reports honoraria from Novartis, Sanofi Pasteur, and GSK; consulting fees from Sanofi Pasteur and Moderna, and consulting the World Health Organization and CDC Foundation outside the submitted work. All other authors report no conflicts of interest. Dafna Yahav is an Editorial Board member of Infectious Diseases and Therapy. Dafna Yahav was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This study was approved by the local ethics committee (SMC-1438-24) per the Helsinki Declaration.
